Novimed Pharmaceutical Private Limited
About Novimed Pharmaceutical Private Limited
Data last updated:
Novimed Pharmaceutical Private Limited is a private limited company based in Aligarh, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51397UP2021PTC145617. Its GSTIN is 09AAHCN5707F1ZE (Uttar Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nadeem and Atiya Tabassum.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Mohd Ashfaq 0 Nikat Palaki Loug Manzoorgarhi Byepass Aligarh, Uttar Pradesh, India – 202001.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.14 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹19,562 (net margin -3.2%) and EBITDA of -₹19,562 (EBITDA margin -3.2%).
Company details
Contact details
Novimed Pharmaceutical Private Limited's registered office is in Aligarh, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Mohd Ashfaq 0 Nikat Palaki Loug Manzoorgarhi Byepass Aligarh, Uttar Pradesh, India – 202001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Novimed Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novimed Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Novimed Pharmaceutical Private Limited, buy the company report.
Financials of Novimed Pharmaceutical Private Limited
FY 2025 filings availableNovimed Pharmaceutical Private Limited reported revenue of ₹6.14 Lakh (up 698% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 698% in the latest year. EBITDA fell 554% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹19,562 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹19,562 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -3.2% | |||
| Net Profit Margin | -3.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Novimed Pharmaceutical Private Limited, buy the company report.
Board of directors of Novimed Pharmaceutical Private Limited
Novimed Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nadeem | Director | 26 Apr 2021 | 5 Years 6 Months | Current |
| Atiya Tabassum | Director | 26 Apr 2021 | 5 Years 6 Months | Current |
| Naeem | Director | 26 Apr 2021 | 5 Years 6 Months | Current |
Peer comparison
Novimed Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sree Mathilakam Food Products Private Limited | ₹6.54 Lakh (FY 2025) | 167.0% | Malayinkil, Kerala, India | |||
| Oncure Drugs Private Limited | ₹6.4 Lakh (FY 2024) | -64.0% | Mumbai, Maharashtra, India | |||
| Medicean Pharmaceuticals Private Limited | ₹6.23 Lakh (FY 2025) | 19.0% | Lucknow, Uttar Pradesh, India | |||
| Sood Paper and Allied Chemicals Private Limited | ₹6.2 Lakh (FY 2024) | 1.0% | Mumbai, Maharashtra, India | |||
| Madhurhealth and Nutrition Private Limited | ₹6.16 Lakh (FY 2025) | -20.0% | Pune, Maharashtra, India | |||
| Novimed Pharmaceutical Private Limitedthis company | ₹6.14 Lakh (FY 2025) | -₹19,562 | -3.2% | 698.0% | Aligarh, Uttar Pradesh, India | |
| Bigbrand Creations Private Limited | ₹6.1 Lakh (FY 2024) | Aligarh, Uttar Pradesh, India | ||||
| Westfield Hygiene Private Limited | ₹6.09 Lakh (FY 2024) | 4893.0% | Mumbai, Maharashtra, India | |||
| Sanboreg Manufacturing and Technologies (OPC) Private Limited | ₹6.03 Lakh (FY 2025) | Bangalore, Karnataka, India | ||||
| Absolute Healthworks Private Limited | ₹6.02 Lakh (FY 2025) | 58.0% | Pune, Maharashtra, India | |||
| Innogent Pharmaceuticals Private Limited | ₹6.01 Lakh (FY 2025) | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Novimed Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Novimed Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novimed Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Novimed Pharmaceutical Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
GST
Novimed Pharmaceutical has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCN5707F1ZE | Uttar Pradesh | Active | 15 Jul 2021 |
| 09AAHCN5707F2ZD | Uttar Pradesh | Active | 16 Jul 2021 |
To see the full GST registrations and return filing status of Novimed Pharmaceutical Private Limited, buy the company report.
Recent activity
Novimed Pharmaceutical Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Atiya Tabassum was appointed as Director on 26 Apr 2021.
Frequently asked questions
Novimed Pharmaceutical is an active private limited company based in Aligarh, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 April 2021 (5+ years old) and is registered under CIN U51397UP2021PTC145617.
Novimed Pharmaceutical has 3 current directors:
- Nadeem - Director
- Atiya Tabassum - Director
- Naeem - Director
The latest financial statements of Novimed Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Novimed Pharmaceutical is 09AAHCN5707F1ZE, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAHCN5707F2ZD (Uttar Pradesh).
The CIN (Corporate Identification Number) of Novimed Pharmaceutical is U51397UP2021PTC145617. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novimed Pharmaceutical was incorporated on 26 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Novimed Pharmaceutical by revenue are Sree Mathilakam Food Products Private Limited, Oncure Drugs Private Limited, Medicean Pharmaceuticals Private Limited, Sood Paper and Allied Chemicals Private Limited, Madhurhealth and Nutrition Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Atiya Tabassum was appointed as Director on 26 Apr 2021. Nadeem was appointed as Director on 26 Apr 2021. Naeem was appointed as Director on 26 Apr 2021.
The registered office of Novimed Pharmaceutical is at CO Mohd Ashfaq 0 Nikat Palaki Loug Manzoorgarhi Byepass Aligarh, Uttar Pradesh, India – 202001.
Novimed Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Novimed Pharmaceutical can be reached at its registered office: CO Mohd Ashfaq 0 Nikat Palaki Loug Manzoorgarhi Byepass Aligarh, Uttar Pradesh, India – 202001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
